Fecal Microbiota Transplant involves transferring rigorously screened stool from a healthy donor into a recipient's gastrointestinal tract. This procedure aims to restore a healthy and diverse microbial community, which is proven to resolve specific infections like recurrent C. diff. For healthspan, the hypothesis is that transplanting a 'young' microbiome could reverse age-related microbial dysbiosis, thereby improving immune function and metabolic health, though this remains highly speculative and unproven in humans.
Verdict
A powerful medical tool for C. diff; unproven and risky for healthspan.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
High
EVIDENCE GRADE
C
MONTHLY COST
$5000 - $15000
Protocol
- For C. diff infection, a single administration via colonoscopy, enema, or oral capsules is the standard of care.
- Healthspan-focused protocols are not established and are currently confined to research settings, often using young, healthy donors.
Flags
- FDA has issued safety alerts regarding transmission of multi-drug resistant organisms, including fatal cases.
- Long-term effects on the recipient's immune system, metabolism, and epigenetics are largely unknown.
- Do-it-yourself (DIY) FMT is extremely dangerous and strongly discouraged due to severe infection risk.
- Thorough and comprehensive donor screening is critical to minimize risk of pathogen transmission.